Studies of otic capsule morphology and gene expression in the Mov13 mouse--an animal model of type I osteogenesis imperfecta.

Studies of otic capsule morphology and gene expression in the Mov13 mouse--an animal model of type I osteogenesis imperfecta. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Studies of otic capsule morphology and gene expression in the Mov13 mouse--an animal model of type I osteogenesis imperfecta. Abstract Text:

Konstantina M Stankovic,Arthur G Kristiansen,Argyro Bizaki,Matthew Lister,Joe C Adams,Michael J McKenna,

Type I osteogenesis imperfecta (OI) is a disorder of skeletal bones characterized by bone fragility and blue sclera, which can result from mutations in genes encoding for type I collagen--the COL1A1 and COL1A2 genes. Fifty percent of patients with type I OI develop hearing loss and associated histopathological changes in the otic capsule that are indistinguishable from otosclerosis, a major cause of acquired hearing loss. In an attempt to elucidate molecular and cellular mechanisms of hearing loss in type I OI, we have studied the Mov13 mouse, which has served as an animal model of type I OI by virtue of exhibiting variable transcriptional block of the COL1A1 gene. We studied the morphometry of the Mov13 otic capsule and compared expression levels of 60 genes in the otic capsule with those in the tibia and parietal bone of the Mov13 and wild-type mice. The degree of transcriptional block of the COL1A1 gene and its downstream effects differed significantly between the bones examined. We found that expression levels of bone morphogenetic protein 3 and nuclear factor kappa-B1 best distinguished Mov13 otic capsule from wild-type otic capsule, and that osteoprotegerin, caspase recruitment domain containing protein 1, and partitioning defective protein 3 best distinguished Mov13 otic capsule from Mov13 tibia and parietal bone. Although the Mov13 mouse did not demonstrate evidence of active abnormal otic capsule remodeling as seen in type I OI and otosclerosis, studying gene expression in the Mov13 mouse has provided evidence that osteocytes of the otic capsule differ from osteocytes in other bones.

Studies of otic capsule morphology and gene expression in the Mov13 mouse--an animal model of type I osteogenesis imperfecta. Publishing Authors By Initials

KM Stankovic,AG Kristiansen,A Bizaki,M Lister,JC Adams,MJ McKenna,

For similar musculoskeletal system: skeleton: bone and bones: skull: temporal bone research abstracts see: musculoskeletal system: skeleton: bone and bones: skull: temporal bone research

PUBMED ID PMID:

MEDLINE DATE:

Studies of otic capsule morphology and gene expression in the Mov13 mouse--an animal model of type I osteogenesis imperfecta. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Audiology & neuro-otology

VOLUME: 12

Page Numbers: 334-43

Journal Abbreviation: Audiol. Neurootol.

ISSN: 1421-9700

DAY: 26

MONTH: 06

YEAR: 2007

Studies of otic capsule morphology and gene expression in the Mov13 mouse--an animal model of type I osteogenesis imperfecta. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9606930

Studies of otic capsule morphology and gene expression in the Mov13 mouse--an animal model of type I osteogenesis imperfecta. Keywords Mesh Terms:

KEYWORDS: Temporal Bone

MESH TERMS: anatomy & histology

Chemical & Substance for Abstract: Studies of otic capsule morphology and gene expression in the Mov13 mouse--an animal model of type I osteogenesis imperfecta. Information

Substance Name: Collagen

Registry Number: 9007-34-5

Grant and Affiliation Information for Studies of otic capsule morphology and gene expression in the Mov13 mouse--an animal model of type I osteogenesis imperfecta.

AFFILIATION: Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, Mass. 02114-3096, USA.

Country: Switzerland

AGENCY: United States NIDCD

GRANT: 5R01 DC03401-08

ACRONYM: DC

MEDLINETA: Audiol Neurootol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Studies of otic capsule morphology and gene expression in the Mov13 mouse--an animal model of type I osteogenesis imperfecta Related Publications

• A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy.
• A prospective randomized controlled trial of lifestyle intervention on quality of life and cardiovascular risk score in patients with obesity and type 2 diabetes.
• Appropriate interpretation of the athlete's electrocardiogram saves lives as well as money.
• Atomic crystal and molecular dynamics simulation structures of human carbonic anhydrase II: insights into the proton transfer mechanism.
• Capacity building in nursing and midwifery research and development: an old priority with a new perspective.
• Comparison of bacterial culture, histopathology, and immunohistochemistry for the diagnosis of Johne's disease in culled dairy cows.
• Confabulation in schizophrenia and its relationship to clinical and neuropsychological features of the disorder.
• Cultural adaptation of quality of life measures.
• Current research in otosclerosis.
• Hyperoxic reperfusion after global ischemia decreases hippocampal energy metabolism.
• Identification and characterization of canine dendritic cells generated in vivo.
• Information-seeking behaviour of men newly diagnosed with cancer: a qualitative study.
• Kinetic parameters and lactate dehydrogenase isozyme activities support possible lactate utilization by neurons.
• Methods of fluorine and fluoride analysis--I.
• Methods of fluorine and fluoride analysis--II.
• Modified mandibular condylotomy.
• Never-ending making sense: towards a substantive theory of the information-seeking behaviour of newly diagnosed cancer patients.
• Pre-eclampsia affects pulmonary function in pregnancy.
• Preface.
• Prenatally detected hydronephrosis: impact on postnatal outcomes.
• Review of "the healing forest: medicinal and toxic plants of the northwest amazonia".
• Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
• Solvent-mediated proton transfer in catalysis by carbonic anhydrase.
• Studies of otic capsule morphology and gene expression in the Mov13 mouse--an animal model of type I osteogenesis imperfecta.
• Superior semicircular canal dehiscence mimicking otosclerotic hearing loss.
• The glutamate-glutamine cycle is not stoichiometric: Fates of glutamate in brain.
• The novel apolipoprotein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following cortical contusion injury.
• United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).
• Verrucous carcinoma.
• Walking and Work Performance in a University Community: A Feasibility Study: 1364: Board #127 May 30 11:00 AM - 12:30 PM.